Drug

Eloralintide clinical trials

Also written LY3841136.

studies test it: 24
open now: 14
in phase 3: 7
first study started: 2022

Keep track of what changes. Save the eloralintide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

24 studies that test it; most in 2026 (14)

Studies that test eloralintide, by start year
Year	Studies
2022	1
2023	1
2024	4
2025	4
2026	14

By phase

A phase 1/2 study counts in both.

Phase 1: 12
Phase 2: 5
Phase 3: 7

What it is tested for

Each study’s main condition, where its own words name it.

Obesity: 18
Kidney Failure, Chronic: 1
Overweight: 1
Osteoarthritis: 1
Sleep Apnea, Obstructive: 1
Hepatic Insufficiency: 1

Who runs them

Industry 24 · Other 0

Eli Lilly and Company (24)

Often tested with

Tested in the same studies.

Tirzepatide (6) · Macupatide (4) · Mazdutide (1) · Naperiglipron (1)

Studies

Open first, then newest update. How each study uses eloralintide is read from its arms, and is right about nine times in ten.

Testing it · 24

See all 24 studies that test eloralintide →

Codes

What other systems call eloralintide · ClinicalTrials.gg INT015388

UNII (FDA) 73G3354J8WELORALINTIDEOne source FDA
NCI Thesaurus C206906EloralintideOne source FDA

System	Code	Name there	Checked by
UNII (FDA)	73G3354J8W	ELORALINTIDE	One source FDA
NCI Thesaurus	C206906	Eloralintide	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.